[PDF] Top 20 De la ecuación de Boltzmann a Navier-Stokes
Has 515 "De la ecuación de Boltzmann a Navier-Stokes" found on our website. Below are the top 20 most common "De la ecuación de Boltzmann a Navier-Stokes".
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease
... outpatient pharmacy claims from more than 70 US health plans covering more than 40 million patients. The dataset had been deidentified in compliance with the patient pri- vacy regulations of the US Health Insurance ... See full document
18
<p>Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study</p>
... LAMA/LABA therapy demonstrates signi fi cant improvements in lung function, reduced exacerbation risk and rescue medica- tion use and a lower risk of pneumonia relative to ICS/ ...function versus FP/SAL in ... See full document
10
A US database study characterizing patients initiating a budesonide–formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease
... tiotropium therapy had important differences prior to the start of ...controller therapy compared with tiotropium initiators, which may be indicative of more severe disease or attributable to a ... See full document
8
Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
... tiotropium, salmeterol or no treatment). The maintenance therapy branch represents alternate treatment option for those patients who do not continue on ...on maintenance therapy. The ... See full document
8
Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease
... initiated fluticasone/salmeterol had at least one fill of a nonindex long-acting bronchodilator during the baseline ...and fluticasone/salmeterol cohorts, respectively, the distribution of age ... See full document
11
Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol
... FF/UMEC/VI therapy and the other with ...triple therapy, compared with a worsening of FEV 1 , of about 29 mL, in those who had received the ICS + LABA ... See full document
27
Vulnerable COPD patients with comorbidities: the role of roflumilast
... of chronic obstructive pulmonary disease ...bronchodilator therapy in the Caucasian and Asian popula- ...COPD, chronic bronchitis, and frequent history of exacerbations derived ... See full document
5
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis
... budesonide, fluticasone propionate, triamcinolone, bambuterol, formoterol, sal- meterol, salbutamol, indacaterol, theophylline, roflumi- last, indacaterol maleate, ipratropium bromide, vilanterol ... See full document
33
Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database
... Methods: We identified a cohort of patients aged 45 years and over with COPD in the General Practice Research Database (GPRD) between 2003 and 2006. Cases of incident cataracts or glaucoma were defined based on diagnosis ... See full document
18
When is dual bronchodilation indicated in COPD?
... in combination with exercise training, did not significantly improve physical activity compared with placebo, although a significant reduc- tion in symptom burden was ... See full document
5
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
... Table 3 summarizes the major clinical trials that have examined the use of FF as an ICS maintenance asthma therapy. Efficacy and safety have been verified with once- daily FF dosing in asthmatic patients in ... See full document
6
Comparison of heat sensitive moxibustion versus fluticasone/salmeterol (seretide) combination in the treatment of chronic persistent asthma: design of a multicenter randomized controlled trial
... Canon is an ancient Chinese medical text that has been treated as the fundamental doctrinal source for Chinese medicine for more than two millennia and until today. According with its core viewpoint and theory, acupoint ... See full document
8
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
... cardiovascular disease was significantly greater in the smoking cessation plus ipratropium group compared to the smoking cessation plus placebo group (P = ...heart disease deaths and the combination ... See full document
13
The lung function profile of once-daily tiotropium and olodaterol via Respimat<sup>®</sup> is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler<sup>®</sup> (ENERGITO<sup>®</sup> study)<div><br /></div>
... require maintenance treatment with the goal of improving lung function, with associated symptomatic and health-status benefits, tiotropium + olodaterol should be considered as another treatment option that offers ... See full document
16
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial
... Once-daily UMEC/VI 62.5/25 mcg over 12 weeks signifi- cantly improved lung function in symptomatic patients with moderate-to-severe COPD with no exacerbations in the year prior to enrolment versus twice-daily ... See full document
11
Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy
... a balanced step-down therapeutic protocol with 100 mg SFC efficiently maintains the FeNO level, ACT score, and %FEV 1 , %FEF 25 , and %FEF 50 values stable for at least 12 months. In contrast, switching to high-dose ICS ... See full document
9
The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
... received fluticasone propionate or salmeterol ...of combination therapy was seen, as the PEF mean change from baseline was greater than the sum of the changes achieved with ... See full document
15
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium
... In general, once-daily dosing of QVA149 is well ac- cepted by COPD patients [5]. Moreover, the combined use of indacaterol and glycopyrronium is further favoured by the inhalation device used. In fact, the dry powder in- ... See full document
35
Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population
... corticosteroids, combination inhaled corticosteroids/long-acting beta-agonists, methylxanthines, oral corticosteroids, and antibiotics for respiratory infections) identified using national drug codes, health care ... See full document
211
Indacaterol: a comprehensive review
... Abstract: At present there is no cure for chronic obstructive pulmonary disease (COPD). However, some nonpharmacologic treatments, such as rehabilitation and lung volume reduction surgery, as ... See full document
5
Related subjects